qSOFA预测肺炎死亡率优于次要标准、劣于CURB-65,且要素稳健、收敛性更高
该前瞻性观察性队列纳入2116例社区获得性肺炎患者,总体院内死亡率6.43%。qSOFA≥2者死亡率25.96%,qSOFA<2者3.05%(OR 6.57,P<0.0001);IDSA/ATS次要标准≥3条者死亡率13.85%,≤2条者2.03%(OR 2.27,P<0.0001)。qSOFA预测死亡的AUROC为0.868,优于次要标准(0.824),与肺炎严重指数相当,但劣于CURB-65(0.919)。qSOFA≥2敏感性59.6%、特异性88.3%,较次要标准≥3条更特异但更不敏感。作者认为qSOFA可作为床旁提示指标,作为次要标准的替代,提高对预后不良CAP患者的识别。
要点
- qSOFA≥2预测CAP院内死亡的OR为6.57(P<0.0001),死亡率25.96% vs qSOFA<2的3.05%。
- IDSA/ATS次要标准≥3条预测死亡的OR为2.27(P<0.0001),死亡率13.85% vs ≤2条的2.03%。
- qSOFA≥2敏感性59.6%、特异性88.3%、阳性似然比5.11;次要标准≥3条敏感性80.1%、特异性65.8%、阳性似然比2.34。
- qSOFA预测死亡的AUROC为0.868,优于次要标准(0.824),与肺炎严重指数相当,劣于CURB-65(0.919)。
- qSOFA内部一致性Cronbach α为0.43,高于次要标准的0.14,各要素诊断价值(AUROC和约登指数)也更大。
适用人群与场景
- 社区获得性肺炎(CAP)患者,前瞻性观察性队列共2116例。
诊断标准与关键阈值
- qSOFA评分≥2分定义为高危(原文以qSOFA score of 2 or higher为阈值)。
- IDSA/ATS次要标准≥3条定义为高危(原文以at least 3 minor criteria为阈值)。
研究设计与关键结果
- 研究类型为前瞻性观察性队列,纳入2116例CAP患者;总体院内死亡率为6.43%。
- qSOFA≥2组院内死亡率为25.96%,qSOFA<2组为3.05%,死亡OR为6.57(P<0.0001)。
- IDSA/ATS次要标准≥3条组院内死亡率为13.85%,≤2条组为2.03%,死亡OR为2.27(P<0.0001)。
- qSOFA≥2预测死亡的敏感性59.6%、特异性88.3%、阳性似然比5.11;次要标准≥3条敏感性80.1%、特异性65.8%、阳性似然比2.34。
- qSOFA预测死亡的AUROC为0.868,次要标准为0.824,肺炎严重指数为0.902,CURB-65为0.919;qSOFA的判别能力统计上优于次要标准,与肺炎严重指数相等,劣于CURB-65。
- qSOFA与次要标准相比的净重分类改善(NRI)为0.088,与肺炎严重指数相比NRI为-0.068,与CURB-65相比NRI为-0.103。
- qSOFA内部一致性Cronbach α为0.43,次要标准为0.14;qSOFA各要素的AUROC和约登指数均更大。
证据类型、等级与局限
- 证据类型:前瞻性观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为qSOFA作为床旁提示指标,可能作为次要标准的替代,提高对预后不良CAP患者的识别,从而有助于更恰当的临床分诊决策。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Limited data are available on the discriminatory capacity of quick sequential [sepsis-related] organ failure assessment (qSOFA) versus IDSA/ATS minor criteria for predicting mortality in patients with community-acquired pneumonia (CAP).
METHODS: An observational prospective cohort study of 2116 patients with CAP was performed. Construct validity was determined using Cronbach α. Discrimination was assessed using the area under the receiver operating characteristic curve (AUROC) and net reclassification improvement (NRI).
RESULTS: Overall in-hospital mortality was 6.43%. Mortality was 25.96% for patients with a qSOFA score of 2 or higher versus 3.05% for those with a qSOFA score less than 2 (odds ratio for mortality 6.57, P < 0.0001), and 13.85% for patients with at least 3 minor criteria versus 2.03% for those with 2 or fewer minor criteria (odds ratio for mortality 2.27, P < 0.0001). qSOFA had a higher correlation with mortality than minor criteria, as well as higher internal consistency (Cronbach alpha 0.43 versus 0.14) and diagnostic values of individual elements (larger AUROCs and higher Youden's indices). qSOFA ≥2 was less sensitive but more specific for predicting mortality than ≥3 minor criteria (qSOFA sensitivity 59.6%, specificity 88.3% and positive likelihood ratio 5.11 versus ≥3 minor criteria sensitivity 80.1%, specificity 65.8% and positive likelihood ratio 2.34). The predictive validity of qSOFA was good for mortality (AUROC = 0.868), was statistically greater than minor criteria, was equal to pneumonia severity index, and was inferior compared with CURB-65 (AUROC, 0.824, 0.902, 0.919; NRI, 0.088, -0.068, -0.103; respectively).
CONCLUSIONS: The qSOFA predicted mortality in CAP better than IDSA/ATS minor criteria and worse than CURB-65 with robust elements and higher convergence. qSOFA as a bedside prompt might be positioned as a proxy for minor criteria and increase the recognition and thus merit more appropriate management of CAP patients likely to fare poorly, which might have implications for more accurate clinical triage decisions.
参考来源
- Guo Q, Li HY, Song WD, et al. qSOFA predicted pneumonia mortality better than minor criteria and worse than CURB-65 with robust elements and higher convergence. Am J Emerg Med. 2021. PMID: 34856439. doi:10.1016/j.ajem.2021.11.029
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。